Role of ASpirin in Placental and Maternal Endothelial Cell Regulation IN Pre-eclampsia

NCT03893630 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

208

Enrollment

OTHER

Sponsor class

Conditions

Pre-Eclampsia

Interventions

DRUG: Acetylsalicylic Acid 81 mg
DRUG: Acetylsalicylic Acid 162 mg
OTHER: Control

Sponsor

John O'Brien, MD